NDC Code(s) : 68180-150-01
Packager : Lupin Pharmaceuticals, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
| FamotidineFamotidine POWDER, FOR SUSPENSION | ||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
| LABELER - Lupin Pharmaceuticals, Inc.(089153071) |
| REGISTRANT - LUPIN LIMITED(675923163) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| LUPIN LIMITED | 677600414 | MANUFACTURE(68180-150), PACK(68180-150) | |
PRINCIPAL DISPLAY PANEL

NDC 68180-150-01
Famotidine for Oral Suspension USP
40 mg/5 mL
50 mL (when reconstituted)







